| __timestamp | Mesoblast Limited | United Therapeutics Corporation |
|---|---|---|
| Wednesday, January 1, 2014 | 25980000 | 1288519000 |
| Thursday, January 1, 2015 | 23748000 | 1465761000 |
| Friday, January 1, 2016 | 42548000 | 1598800000 |
| Sunday, January 1, 2017 | 2412000 | 1725300000 |
| Monday, January 1, 2018 | 17341000 | 1627800000 |
| Tuesday, January 1, 2019 | 16722000 | 1448800000 |
| Wednesday, January 1, 2020 | 32156000 | 1483300000 |
| Friday, January 1, 2021 | 7456000 | 1685500000 |
| Saturday, January 1, 2022 | 10211000 | 1936300000 |
| Sunday, January 1, 2023 | 7501000 | 2327500000 |
| Monday, January 1, 2024 | 5902000 |
Unveiling the hidden dimensions of data
In the ever-evolving landscape of biotechnology, revenue trends offer a glimpse into the financial health and strategic direction of companies. United Therapeutics Corporation, a leader in the field, has shown a robust revenue growth trajectory from 2014 to 2023, with a remarkable increase of approximately 80% over this period. In contrast, Mesoblast Limited, while innovative, has faced more volatility, with revenues peaking in 2016 and then experiencing fluctuations.
United Therapeutics' revenue surged from $1.29 billion in 2014 to an impressive $2.33 billion in 2023, reflecting its strong market position and successful product portfolio. Meanwhile, Mesoblast's revenue, which reached its zenith in 2016, has seen a decline, highlighting the challenges faced by smaller biotech firms in maintaining consistent growth. The data for 2024 is incomplete, indicating potential shifts in the coming year.
Johnson & Johnson and Mesoblast Limited: A Comprehensive Revenue Analysis
Vertex Pharmaceuticals Incorporated or Mesoblast Limited: Who Leads in Yearly Revenue?
Alnylam Pharmaceuticals, Inc. and Mesoblast Limited: A Comprehensive Revenue Analysis
Breaking Down Revenue Trends: Teva Pharmaceutical Industries Limited vs Mesoblast Limited
Annual Revenue Comparison: United Therapeutics Corporation vs BioMarin Pharmaceutical Inc.
Revenue Showdown: United Therapeutics Corporation vs Alkermes plc
United Therapeutics Corporation and ADMA Biologics, Inc.: A Comprehensive Revenue Analysis
United Therapeutics Corporation or BioCryst Pharmaceuticals, Inc.: Who Leads in Yearly Revenue?
United Therapeutics Corporation and Evotec SE: A Comprehensive Revenue Analysis
Lantheus Holdings, Inc. vs Mesoblast Limited: Annual Revenue Growth Compared
MorphoSys AG vs Mesoblast Limited: Examining Key Revenue Metrics
Who Generates More Revenue? Mesoblast Limited or Amphastar Pharmaceuticals, Inc.